Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
Clinical Infectious Diseases2009Vol. 49(11), pp. 1721–1728
Citations Over TimeTop 10% of 2009 papers
Hsin‐Yun Sun, Barbara D. Alexander, Olivier Lortholary, Françoise Dromer, Graeme N. Forrest, G. Marshall Lyon, Jyoti Somani, Krishan Lal Gupta, Ramon Del Busto, Timothy L. Pruett, Costi D. Sifri, Ajit P. Limaye, George John, Göran B. Klintmalm, Kenneth Pursell, Valentina Stosor, Michelle I. Morris, Lorraine A. Dowdy, Patricia Muñóz, André C. Kalil, Julia Garcia‐Diaz, Susan L. Orloff, Andrew A. House, Sally Houston, Dannah Wray, Shirish Huprikar, Leonard B. Johnson, Atul Humar, Raymund R. Razonable, Shahid Husain, Nina Singh
Abstract
Lipid formulations of amphotericin B were independently associated with better outcome and may be considered as the first-line treatment for CNS cryptococcosis in these patients.
Related Papers
- → Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System(2004)93 cited
- → BD BACTEC™ Mycosis IC/F culture vials for fungemia diagnosis and follow-up: a retrospective study from 2013 to 2020(2022)3 cited
- Cutaneous manifestation of cryptococcosis in patient with acquired immunodeficiency syndrome (AIDS) - a case report(2012)
- 教育シリーズ : Deep-seated mycosis : Cryptococcosis(2011)